{"hands_on_practices": [{"introduction": "The foundation of innate immunity lies in its ability to recognize molecular signatures unique to microbes but absent from host cells. This exercise challenges you to think like an immunologist faced with a novel organism. By analyzing the biochemical makeup of a microbe's cell wall, you can form a hypothesis about which class of Pattern Recognition Receptors (PRRs) is most likely involved in its initial detection by immune cells [@problem_id:2258892].", "problem": "An immunology research team is investigating the innate immune response to a novel, non-pathogenic fungal species discovered in a deep-sea hydrothermal vent. Biochemical analysis of the fungus's cell wall reveals that it is predominantly composed of mannans, which are complex branched polymers of the sugar mannose. A key goal is to identify the primary host cell surface receptor on macrophages that mediates the initial recognition of this intact fungal organism.\n\nBased on the biochemical nature of this dominant cell wall component, which of the following classes of Pattern Recognition Receptors (PRRs) represents the most logical and specific first target for investigation?\n\nA. Toll-like receptors (TLRs)\n\nB. NOD-like receptors (NLRs)\n\nC. RIG-I-like receptors (RLRs)\n\nD. C-type lectin receptors (CLRs)\n\nE. AIM2-like receptors (ALRs)", "solution": "The question asks for the most logical and specific first target PRR class for initial recognition of an intact fungal organism whose dominant cell wall component is mannans (branched polymers of mannose), focusing on a host cell surface receptor on macrophages.\n\nLogical steps:\n1. Identify the nature of the pathogen-associated molecular pattern (PAMP): mannans are carbohydrate structures composed of mannose residues on fungal cell walls.\n2. Map PAMP class to PRR class with known ligand specificity:\n   - C-type lectin receptors (CLRs) are transmembrane carbohydrate-binding receptors that recognize specific sugar moieties. Within CLRs, the mannose receptor (CD206), DC-SIGN, and dectin-2 are known to recognize high-mannose and alpha-mannan structures; dectin-1 primarily recognizes beta-glucans rather than mannans, but the CLR family collectively includes key mannose/mannan-recognizing receptors.\n   - Toll-like receptors (TLRs) recognize a broad range of ligands including lipopolysaccharide, lipoproteins, flagellin, and nucleic acids; while TLR2 can participate in responses to some fungal components (e.g., zymosan), TLRs are not the most specific for mannose-rich mannans.\n   - NOD-like receptors (NLRs) are cytosolic sensors for intracellular bacterial peptidoglycan motifs and other danger signals; they are not primary cell surface receptors for intact extracellular fungi.\n   - RIG-I-like receptors (RLRs) are cytosolic receptors for viral RNA and are irrelevant for fungal cell wall carbohydrates.\n   - AIM2-like receptors (ALRs) detect cytosolic double-stranded DNA, not cell wall carbohydrates.\n3. Incorporate cellular localization: the question specifies an initial recognition event by a host cell surface receptor on macrophages interacting with an intact organism. This favors membrane-bound extracellular carbohydrate-binding receptors, i.e., CLRs, over cytosolic PRRs.\n4. Conclusion: Given the biochemical nature of the dominant PAMP (mannans) and the requirement for a cell surface receptor mediating initial recognition, CLRs are the most logical and specific first target, specifically those recognizing mannose/mannan structures such as the mannose receptor, DC-SIGN, and dectin-2.", "answer": "$$\\boxed{D}$$", "id": "2258892"}, {"introduction": "While recognizing extracellular threats is crucial, the immune system must also stand guard against invaders that breach the cell's perimeter. This problem explores the critical role of intracellular PRRs through a clinical lens. By examining a specific genetic deficiency in the cyclic GMP-AMP synthase (cGAS) enzyme, you will connect a molecular defect to a predictable vulnerability to certain viruses, highlighting the importance of the cytosolic surveillance system in antiviral defense [@problem_id:2258877].", "problem": "A physician is evaluating a patient with a history of severe and recurrent viral infections, particularly from DNA viruses. Genetic sequencing reveals a rare loss-of-function mutation in the gene encoding the enzyme cyclic GMP-AMP synthase (cGAS). This enzyme is a critical component of the innate immune system's intracellular defense mechanisms. Based on this specific genetic defect, which of the following Pathogen-Associated Molecular Patterns (PAMPs) would the patient's cells primarily fail to recognize, leading to the observed susceptibility to certain viruses?\n\nA. Lipopolysaccharide (LPS) from the outer membrane of gram-negative bacteria.\n\nB. Double-stranded RNA (dsRNA) located within an endosome.\n\nC. Double-stranded DNA (dsDNA) present in the cell's cytoplasm.\n\nD. Flagellin protein from bacterial flagella.\n\nE. Peptidoglycan fragments from a bacterial cell wall.", "solution": "We are told the patient has a loss-of-function mutation in cyclic GMP-AMP synthase (cGAS), which is a cytosolic DNA sensor in the innate immune system. The relevant innate immune principle is that cGAS binds double-stranded DNA present in the cytosol in a sequence-independent manner. Upon binding cytosolic double-stranded DNA, cGAS catalyzes the synthesis of the second messenger cyclic GMP-AMP (cGAMP) from ATP and GTP. cGAMP activates the adaptor STING on the endoplasmic reticulum membrane, which triggers downstream signaling via TBK1 and IRF3, culminating in type I interferon responses crucial for antiviral defense, especially against DNA viruses that introduce or generate DNA in the cytoplasm.\n\nTherefore, a loss-of-function in cGAS would specifically impair recognition of double-stranded DNA present in the cytoplasm, leading to defective cGAMP production and blunted STING pathway activation.\n\nNow evaluate the options by mapping each PAMP to its canonical pattern-recognition receptor and cellular compartment:\n- Lipopolysaccharide from gram-negative bacteria is recognized primarily by TLR4 at the cell surface, not by cGAS. Thus, this is not the impaired recognition.\n- Double-stranded RNA in an endosome is recognized by TLR3; cytosolic dsRNA can be recognized by RIG-I or MDA5. These are RNA sensors, not the cGAS-STING DNA-sensing pathway.\n- Double-stranded DNA in the cytoplasm is the canonical ligand for cGAS; loss of cGAS directly prevents recognition of this PAMP.\n- Flagellin is recognized by TLR5, not by cGAS.\n- Peptidoglycan is recognized by TLR2 on the surface and by cytosolic NOD1/NOD2 for specific muropeptides, not by cGAS.\n\nThe only PAMP whose detection depends on cGAS is double-stranded DNA in the cytoplasm. Therefore, the patient’s cells would primarily fail to recognize double-stranded DNA present in the cell’s cytoplasm.", "answer": "$$\\boxed{C}$$", "id": "2258877"}, {"introduction": "In complex environments like the gut, the immune system's task is not just to activate, but to modulate its response, tolerating beneficial microbes while attacking pathogens. This practice delves into the elegant mechanism of competitive antagonism at the receptor level. Using a quantitative model, you will calculate how a signal from a harmless commensal bacterium can suppress a pro-inflammatory response, demonstrating how PRR signaling is fine-tuned to maintain homeostasis [@problem_id:2258893].", "problem": "In the complex ecosystem of the human gut, the immune system must distinguish between pathogenic and commensal microbes. This discrimination is partly mediated by Pattern Recognition Receptors (PRRs) on the surface of intestinal epithelial cells. Consider a simplified model where the activation of Toll-like Receptor 4 (TLR4) by a specific ligand triggers a pro-inflammatory response.\n\nThe ligand for TLR4 is a component of Lipopolysaccharide (LPS), a molecule found in the outer membrane of Gram-negative bacteria. An intestinal pathogen produces an agonistic form of LPS, denoted $L_A$, which binds to TLR4 and robustly activates it. In a localized region of the gut mucosa, this pathogenic LPS is present at a constant effective concentration of $[L_A] = 10.0$ nM. A beneficial commensal bacterium, however, produces a structural variant of LPS, denoted $L_B$, which acts as a competitive antagonist. This antagonist binds to the same site on TLR4 but fails to induce a signal, thereby blocking the binding of the agonist, $L_A$.\n\nThe binding equilibria for the agonist and antagonist are described by their respective dissociation constants:\n- Agonist binding: $K_A = 20.0$ nM\n- Antagonist binding: $K_B = 5.00$ nM\n\nThe strength of the pro-inflammatory signal, $S$, is directly proportional to the fraction of TLR4 receptors occupied by the agonist, $\\theta_A$. For simplicity, we can set the signal strength equal to this fraction, such that $S = \\theta_A$. A significant inflammatory response, leading to tissue damage, is initiated if the signal strength $S$ exceeds a critical threshold of $0.10$.\n\nTo maintain intestinal homeostasis in the presence of the pathogen, what is the minimum concentration of the commensal-derived antagonist, $[L_B]$, required to suppress the pro-inflammatory signal to exactly this threshold value of $0.10$? Express your answer in units of nM, rounded to three significant figures.", "solution": "The fraction of TLR4 receptors occupied by the agonist $L_{A}$ in the presence of a competitive antagonist $L_{B}$ is given by the competitive binding isotherm from the law of mass action:\n$$\n\\theta_{A}=\\frac{\\frac{[L_{A}]}{K_{A}}}{1+\\frac{[L_{A}]}{K_{A}}+\\frac{[L_{B}]}{K_{B}}}.\n$$\nThe signal strength is $S=\\theta_{A}$, and we require $S=0.10$. Substituting the given values $[L_{A}]=10.0\\ \\text{nM}$, $K_{A}=20.0\\ \\text{nM}$, and $K_{B}=5.00\\ \\text{nM}$, first compute\n$$\n\\frac{[L_{A}]}{K_{A}}=\\frac{10.0}{20.0}=0.5.\n$$\nLet $x=\\frac{[L_{B}]}{K_{B}}$. Then\n$$\nS=\\frac{0.5}{1+0.5+x}=\\frac{0.5}{1.5+x}.\n$$\nImpose the threshold condition $S=0.10$:\n$$\n\\frac{0.5}{1.5+x}=0.10 \\;\\;\\Rightarrow\\;\\; 0.5=0.10(1.5+x)\\;\\;\\Rightarrow\\;\\; 0.5=0.15+0.10x\n$$\n$$\n\\Rightarrow\\;\\; 0.35=0.10x \\;\\;\\Rightarrow\\;\\; x=3.5.\n$$\nRecover $[L_{B}]$ using $x=\\frac{[L_{B}]}{K_{B}}$:\n$$\n[L_{B}]=xK_{B}=3.5\\times 5.00\\ \\text{nM}=17.5\\ \\text{nM}.\n$$\nRounded to three significant figures, the minimum antagonist concentration required is $17.5$ in units of nM.", "answer": "$$\\boxed{17.5}$$", "id": "2258893"}]}